DISCLAIMER: This link was displayed at 19:06:46 27/07/2024 and expires on 01/08/2024 if printed.

Go to http://testguide.adhb.govt.nz/EGuide/ for more information.

Myotonic Dystrophy
Short Description : Myotonic dystrophy genetic testing
Also known as : [Myotonic Dystrophy Type 1 Testing]


DNA/RNA
Test performed by: LabPLUS - Dept. Diagnostic Genetics - Molecular Genetics


Referral Requirements

Important Note:

Diagnostic testing requires referral through Neurology, Paediatrics or Genetic Services.

Predictive testing only through Genetic Services.

Contacts:

Genetic Health Service NZ can be contacted on 0800 476 123.

Neurology can be contacted on (09) 307 4949 ext. 25662.

General Paediatrics can be contacted on (09) 307 4949 ext. 22559.


Specimen Collection
EDTA4 mL Paediatric EDTA Blood (Preferred)

Note:

For paediatric samples a minimum of 0.5ml blood EDTA can be processed. (Microcollect)

Transport all bloods at room temperature within 24-48 hours. If necessary specimens can be refrigerated overnight for transport at room temperature the following day.

For testing of other sample types please contact the laboratory prior to sending.


EDTA4 mL Adult EDTA Blood
Turnaround Time: Within 6 weeks

Urgent TAT for prenatal/neonatal analysis: 2 weeks


Assay Method

METHOD: A standard PCR-based amplification and subsequent fluorescence-based capillary electrophoresis are used to detect CTG repeat expansions within the DMPK gene - NM_004409.5. Forward and reverse Triplet-repeat Primed (TP) PCR amplification and subsequent fluorescence-based capillary electrophoresis are used to detect all sizes of expansion within the DMPK gene. Due to the nature of the assays, we estimate that the number of each CTG repeat is correct to within plus or minus one for alleles within the normal range, and up to plus or minus three for alleles within the affected range up to 150 repeats.


Diagnostic Use and Interpretation

Myotonic dystrophy type 1 (DM1) is caused by expansion of a CTG trinucleotide repeat in the DMPK gene. The diagnosis of DM1 is suspected in individuals with characteristic muscle weakness and is confirmed by molecular genetic testing of DMPK gene.

IMPORTANT NOTES : the clinical presentation should be provided. Failure to provide the clinical detail required may delay testing.

REFERRAL REQUIREMENTS :
Diagnostic testing requires referral through Neurology, Paediatrics or Genetic Services. Predictive testing only through Genetic Services.


Contact Information

To contact the Molecular Genetics team:

Auckland City Hospital (09) 307 4949
Lablink ext 22000
Molecular Genetics Office ext 22014


Specimen Transport Instructions for Referring Laboratories

Transport all bloods between >8 degrees C to <24 degrees C within 24-48 hours. If necessary specimens can be refrigerated overnight for transport at the temperatures stated above the following day.

For testing of other sample types please contact the laboratory prior to sending.



Last updated at 13:49:36 18/07/2024